Morningside Pharmaceuticals add Mawdsleys as a distributor to Hospitals

Morningside Pharmaceuticals add Mawdsleys as a distributor to Hospitals 4th March 2021

Mawdsleys is delighted to now be partnering with Morningside Pharmaceuticals as an additional distributor to supply their contract and non-contract products to hospitals.

Morningside has a portfolio of 242 generic and branded licensed medicines in the UK and EU and is a proud manufacturer and supplier to NHS Trusts, pharmacy chains, pharmaceutical wholesalers, as well as clinics and dispensing doctors in the UK.

Morningside’s products are available for customers to order now from Mawdsleys.

Other latest news

Mawdsleys and Meabco launch a Named Patient Supply program for BP-C1

Mawdsleys and Meabco A/S have launched a Named Patient Supply program to allow Oncologists within the European Union (EU) to obtain access to BP-C1 on an unlicensed basis for the treatment of metastatic breast cancer and incurable pancreatic cancer. BP-C1 is a new benzene-poly-carboxylic acids complex with cis-diammineplatinum (II)…

We unveil our expanded 3PL warehouse – bigger and greener than before

Press Release Pharmaceutical distributor Mawdsleys unveils its expanded third-party logistics (3PL) warehouse in Doncaster – bigger and greener than before Rt Hon Ed Miliband, Labour MP for Doncaster North and Shadow Secretary of State for Energy Security and Net Zero, officially opens Mawdsleys’ expanded flagship facility today The Redhouse…